News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Yüksel Ürün: SBRT, A powerful option for inoperable RCC
Yüksel Ürün/X
Feb 13, 2025, 07:41

Yüksel Ürün: SBRT, A powerful option for inoperable RCC

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Ludwige Abancourt, et al. on X:

“SBRT: A powerful option for inoperable RCC!

With 96% local control at 5 years, SBRT offers effective, non-invasive treatment while preserving renal function.”

Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series.

Authors: Ludwige Abancourt, et al.

Yüksel Ürün: SBRT, A powerful option for inoperable RCC

Ankara University School of Medicine cancer fight against cancer Global fight against cancer MedOnc OncoDaily Oncology radiation therapy RCC renal cell carcinoma SBRT Yüksel Ürün
Special Coverage
Blog
Feb 13, 2025, 10:27
Chandler Park: The latest cutting-edge data at the 2025 PRIMO meeting
Blog
Feb 13, 2025, 10:22
Mohammad Jad Moussa: Overview of our abstracts for ASCO GU 2025
Blog
Feb 13, 2025, 10:18
Long-Term Outcomes of Radiation Alone vs. Radiation + Hormone Therapy in Low-Risk Elderly Breast Cancer Patients
Blog
Feb 13, 2025, 10:04
Zainab Shinkafi-Bagudu: November 17th is officially recognized as the cervical cancer elimination day of action
Opinion
Feb 13, 2025, 10:03
Ruben Mesa: Intriguing talk on Radiation and Leukemogenesis by Robert Peter Gale
Blog
Feb 13, 2025, 09:52
Antonio Passaro: A must-read for anyone interested in solid tumor cell therapy
Positive
Feb 13, 2025, 09:51
Esosa Omoregie: I have been awarded a Certificate of Membership by the ASBMB
Blog
Feb 13, 2025, 09:50
Thrilled to welcome our new fellow: Raffaella De Pietro - EORTC
Blog
Feb 13, 2025, 09:43
Monika Pansari: HPV can impact anyone, even with just one partner
Blog
Feb 13, 2025, 09:43
Virtual Tumor Board case on EGFR-mutant NSCLC - IASLC
Blog
Feb 13, 2025, 09:35
Peter Pisters: Delighted to share appreciation for our 2024 Heart of MD Anderson recipients
Insight
Feb 13, 2025, 09:30
Petros Grivas: TROPiCS04 P3 trial data has been published